trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['breast', 't-dxd', 'gastric']
t-dxd is an antibody drug conjugate targeting her2 and is approved in her2-expressing breast (bc) and gastric (gc) cancers.
orr =4% for pc 